promising Phase 1 results for a novel Typhoid and iNTS vaccine A new trivalent vaccine designed to protect against typhoid fever and invasive non-typhoidal Salmonella (iNTS) infections has demonstrated encouraging safety and immune responses in a Phase 1 human trial. Developed through a collaboration between the University of Maryland (UM) School of Medicine and Bharat…